For the metastatic model, the signature consisting of CORO1C, RAD23B, GSPT2, and NDN was used to distinguish metastatic (62 LNM and 55 DM) and nonmetastatic (41 NM) CRC. This evidence concerns the gene RAD23B and colorectal carcinoma.